When does TMS (4891.T) report earnings?

TMS Co., Ltd. (4891.T) is scheduled to announce earnings on 20 January 2026. Expect updates on clinical programs, cash runway, and loss guidance that could move the stock in pre-market and intraday trading.

What are the main financial risks for 4891.T stock?

Key risks include ongoing negative EPS (**-15.64**), limited revenue, and binary clinical outcomes. Despite strong cash per share (**JPY 67.81**), further trial costs could dilute value if milestones slip.

What price targets does Meyka AI give for 4891.T stock?

Meyka AI projects a monthly target of **JPY 154.64** (+5.92% vs **JPY 146.00**) and a quarterly target of **JPY 140.32** (-3.90%). These are model-based projections and not guarantees.

How liquid is trading for 4891.T on the JPX?

Pre-market volume is **273,600** against an average of **288,615**, showing near-average liquidity. The share float is modest, so news can cause outsized moves.

JP Stocks

Pre-market earnings ahead: TMS Co., Ltd. (4891.T) JPX at JPY 146.00: what to watch for Jan 20

ByHuzaifa Zahoor January 15, 2026January 15, 2026

The market is watching 4891.T stock ahead of TMS Co., Ltd.’s earnings announcement on 20 January 2026. In pre-market trading on the JPX the share sits at JPY 146.00, up JPY 1.00 (0.69%) from the prior close. Investors will focus on clinical progress for TMS-007, cash reserves per share of JPY 67.81, and guidance that could move this biotech stock before the open.